title: Treatment of HIV-infected fibroblasts with human leukocyte antigen (HLA)-DR-inductive cytokines leads to infectious virions with newly acquired HLA-DR.
authors.forename: M R
authors.initials: MR
authors.lastname: Capobianchi
authors.forename: C
authors.initials: C
authors.lastname: Serra
authors.forename: I
authors.initials: I
authors.lastname: Abbate
authors.forename: P
authors.initials: P
authors.lastname: Marongiu
authors.forename: C
authors.initials: C
authors.lastname: Castilletti
authors.forename: F
authors.initials: F
authors.lastname: Tilocca
authors.forename: F
authors.initials: F
authors.lastname: Dianzani
authors.forename: A
authors.initials: A
authors.lastname: Dolei
mesh_terms: D002352:Carrier Proteins / Q000378:metabolism; D002460:Cell Line; D016207:Cytokines / Q000494:pharmacology; D005347:Fibroblasts / Q000276:immunology / Q000821:virology; D015658:HIV Infections / Q000276:immunology* / Q000821:virology; D015497:HIV-1 / Q000276:immunology*; D006684:HLA-DR Antigens / Q000096:biosynthesis*; D006801:Humans; D018960:Hyaluronan Receptors; D066298:In Vitro Techniques; D018799:Intercellular Adhesion Molecule-1 / Q000378:metabolism; D011956:Receptors, Cell Surface / Q000378:metabolism; D016201:Receptors, Lymphocyte Homing / Q000378:metabolism
chemical_list: D002352:Carrier Proteins; D016207:Cytokines; D006684:HLA-DR Antigens; D018960:Hyaluronan Receptors; D011956:Receptors, Cell Surface; D016201:Receptors, Lymphocyte Homing; D018799:Intercellular Adhesion Molecule-1